Allspring Global Investments Holdings, LLC Apellis Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 72,468 shares of APLS stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,468
Previous 115,453
37.23%
Holding current value
$2.09 Million
Previous $6.79 Million
59.05%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$473 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$335 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$320 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$283 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$167 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.17B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...